| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
1 company
Klausner Richard serves as a Director at LYEL. Across recent SEC filings that breaks down to 1 buy and 2 sells. Those positions are worth an estimated $507K at current prices.
Historically, Klausner Richard's trades have earned a strong insider score of 73/100 across 3 rated trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +68.7%.
The biggest single holding is LYEL (~$507K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 88,880 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2025 | LYEL Lyell Immunopharma, Inc. | Director | Buy | 158,000 | $0.60 | $94,942.20 | +23.1% | -16.8% | +81.5% | |
| Aug 15, 2023 | LYEL Lyell Immunopharma, Inc. | Director | Sell | 58,020 | $2.28 | $132,285.60 | -5.9% | -32.3% | -47.6% | |
| Sep 23, 2022 | LYEL Lyell Immunopharma, Inc. | Director | Sell | 11,100 | $6.40 | $71,041.11 | -1.1% | -52.4% | -77.1% |